UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000049219
Receipt number R000056057
Scientific Title Effects of functional food composition X and aerobic exercise on the risk for lifestyle disease
Date of disclosure of the study information 2024/12/31
Last modified on 2022/10/14 14:09:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of functional food composition X and aerobic exercise on the risk for lifestyle disease

Acronym

Effects of functional food composition X and aerobic exercise on the risk for lifestyle disease

Scientific Title

Effects of functional food composition X and aerobic exercise on the risk for lifestyle disease

Scientific Title:Acronym

Effects of functional food composition X and aerobic exercise on the risk for lifestyle disease

Region

Japan


Condition

Condition

NO

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the combined effect of aerobic exercise with functional foods composition on arterial stiffness and related lifestyle disease.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Cardiovascular indices

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

4

Purpose of intervention

Prevention

Type of intervention

Food Behavior,custom

Interventions/Control_1

Ingestion of functional food and aerobic exercise
*Aerobic exercise training: 45-60min./day,
2 days/Weeks.
*Intervention period: 12-week

Interventions/Control_2

Ingestion of placebo food and aerobic exercise
*Aerobic exercise training: 45-60min./day,
2 days/Weeks.
*Intervention period: 12-week

Interventions/Control_3

Ingestion of functional food (non-exercise)
*Intervention period: 12-week

Interventions/Control_4

Ingestion of placebo food (non-exercise)
*Intervention period: 12-week

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

70 years-old >

Gender

Female

Key inclusion criteria

Japanese women

Key exclusion criteria

1)Individuals who are restricted exercise by their doctors
2)Individuals who have anamnesis of cardiovascular disease
3)Individuals who are using hypertension or hormone medications
4)Smoker
5)Individuals who have allergic reaction to plant
6)Individuals who have a habit of daily vigorous exercises

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Koichiro
Middle name
Last name Hayashi

Organization

Kokugakuin University

Division name

Institute of Health and Physical Education, Department of Human Development

Zip code

225-0003

Address

3-22-1 Shin-Ishikawa, Aoba-ku, Yokohama, Kanagawa 225-0003, Japan

TEL

045-910-3732

Email

k-hayashi@kokugakuin.ac.jp


Public contact

Name of contact person

1st name Koichiro
Middle name
Last name Hayashi

Organization

Kokugakuin University

Division name

Institute of Health and Physical Education, Department of Human Development

Zip code

225-0003

Address

3-22-1 Shin-Ishikawa, Aoba-ku, Yokohama, Kanagawa 225-0003, Japan

TEL

045-910-3732

Homepage URL


Email

k-hayashi@kokugakuin.ac.jp


Sponsor or person

Institute

Kokugakuin University

Institute

Department

Personal name



Funding Source

Organization

Otsuka Pharmaceutical Co., Ltd.

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Border of Kokugakuin University

Address

4-10-28 Higashi, Shibuya-ku, Tokyo 150-8440, Japan

Tel

03-5466-6745

Email

https://www.kokugakuin.ac.jp/


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

國學院大學 横浜たまプラーザキャンパス(神奈川県)(Yokohama Tama Plaza Campus of Kokugakuin University (Kanagawa Prefecture))


Other administrative information

Date of disclosure of the study information

2024 Year 12 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2021 Year 09 Month 01 Day

Date of IRB

2021 Year 09 Month 28 Day

Anticipated trial start date

2021 Year 12 Month 18 Day

Last follow-up date

2023 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 10 Month 14 Day

Last modified on

2022 Year 10 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056057